Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Cancer Immunology, Immunotherapy : CII|April 3, 2012
Mechanism of resistance to trastuzumab and molecular sensitization via ADCC activation by exogenous expression of HER2-extracellular domain in human cancer cellsRyosuke Yoshida, Hiroshi Tazawa, Yuuri Hashimoto, et al.
Gut|May 30, 2014
Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnosticsKunitoshi Shigeyasu, Hiroshi Tazawa, Yuuri Hashimoto, et al.
Breast Cancer Research and Treatment|January 25, 2015
Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cellsKyoko Shimoyama, Shunsuke Kagawa, Michihiro Ishida, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 20, 2014
Biological ablation of sentinel lymph node metastasis in submucosally invaded early gastrointestinal cancerSatoru Kikuchi, Hiroyuki Kishimoto, Hiroshi Tazawa, et al.
Nature Medicine|October 3, 2006
In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirusHiroyuki Kishimoto, Toru Kojima, Yuichi Watanabe, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2012
A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppressionYasumoto Yamasaki, Hiroshi Tazawa, Yuuri Hashimoto, et al.
Cancer Research|November 4, 2010
Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machineryShinji Kuroda, Toshiya Fujiwara, Yasuhiro Shirakawa, et al.
Molecular Cancer Therapeutics|December 3, 2015
Targeted Photodynamic Virotherapy Armed with a Genetically Encoded PhotosensitizerKiyoto Takehara, Hiroshi Tazawa, Naohiro Okada, et al.
International Journal of Cancer|April 12, 2012
Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axisHiroshi Tazawa, Shuya Yano, Ryosuke Yoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2013
A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phasesShuya Yano, Hiroshi Tazawa, Yuuri Hashimoto, et al.
Pageof 4